ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: "NuVasive, Inc." (NUVA) Report Updated: Oct 27, 2014 | Print This Page

Get more stock ratings by Louis Navellier

"NuVasive, Inc." (NUVA)

Rating: Strong Buy Volatility: Moderate
Total Grade: A Industry: Health Care Equipment & Supplies
Competitors: CFN, MSON, NVCN, ZLTQ

Stock Analysis

Rating: Monthly View

A
B
C
D
F
October November December January February March April May June July August September

Rating: Weekly View

This Week: A down upgrade
Last Week: B same no change
Two Weeks Ago: B up downgrade
service keys

"NuVasive, Inc."© quotemedia

Company Profile

NuVasive, Inc., a medical device company, engages in the design, development, and marketing of minimally disruptive surgical products and procedures for the spine. The company’s products focus on applications for spine fusion surgery. It offers products primarily for the thoracolumbar spine and cervical spine. The company’s principal products include a minimally disruptive surgical platform called Maximum Access Surgery (MAS), as well as cervical, biologics, and motion preservation products. Its MAS platform combines four categories of product offerings, including NVM5 and NVJJB, its proprietary software-driven nerve monitoring systems; MaXcess system that provides access to the spine with minimal soft tissue disruption; specialized implants that are used for interbody disc height restoration for fusion and stabilization of the spine, as well as biologic products comprising FormaGraft, a collagen-based synthetic bone substitute and Osteocel Plus, an allograft cellular matrix. Its biologic products also comprise AttraX, a synthetic bone graft material; and Triad, an allograft cellular matrix containing viable mesenchymal stem cells. In addition, the company offers a range of bone allograft in patented saline packaging; disposables and spine implants under the CoRoent brand name; and fixation devices, such as rods, plates, and screws. Further, it provides intra-operative monitoring services for insight into the nervous system during spine and other surgeries. Additionally, the company is developing total disc replacement devices for lateral lumbar spine and cervical spine applications. NuVasive, Inc. sells its products through directly-employed sales shareowners, independent sales agents, and distributors to surgeons and hospitals in the United States and internationally. The company was founded in 1997 and is headquartered in San Diego, California.

Recent News: "NuVasive, Inc."